Evaluation of the utility of capillary electrophoresis for the analysis of sulfobutyl ether beta-cyclodextrin mixtures

被引:23
作者
Luna, EA
Bornancini, ERN
Tait, RJ
Thompson, DO
Stobaugh, JF
Rajewski, RA
Stella, VJ
机构
[1] UNIV KANSAS,HIGUCHI BIOSCI CTR,CTR DRUG DELIVERY RES,LAWRENCE,KS 66047
[2] FAULDING PHARMACEUT,MULGRAVE,VIC,AUSTRALIA
[3] CYDEX LC,OVERLAND PK,KS 66212
[4] UNIV KANSAS,DEPT PHARMACEUT CHEM,LAWRENCE,KS 66047
关键词
anionic cyclodextrin; capillary electrophoresis; sulfobutyl ether cyclodextrin;
D O I
10.1016/0731-7085(96)01826-2
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A capillary electrophoresis (CE) method for the analysis of a sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) mixture is described. The SBE-beta-CD has been prepared as a parenterally safe solubilizing agent and has historically been characterized by elemental analysis and nuclear magnetic resonance spectroscopy. While these methods provide gross values for the degree of substitution, the CE method described resolves the mixture of positional and regional isomers based on the degree of SBE substitution. The method uses benzoic acid in the running buffer and detects the CD by a decrease in background absorbance of the benzoic acid due to complexation. The necessity of a defined column wash sequence between injections was evaluated. The reproducibility of migration times and peak areas/heights for 10 components of the mixture was determined. The modular CE system gave a relative standard deviation of 2.5% (n = 3) for six of the 10 peaks. Further refinements (pH buffer effects) were explored to improve the reproducibility with remaining components. The method was used to evaluate the reproducibility of the synthesis (21 different lots) and the effect of reaction variables (time, temperature and base) on the composition pattern of the modified CD.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 14 条
[1]   CYCLODEXTRINS IN THE PHARMACEUTICAL FIELD [J].
BEKERS, O ;
UIJTENDAAL, EV ;
BEIJNEN, JH ;
BULT, A ;
UNDERBERG, WJM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (11) :1503-1549
[2]   EFFECT OF SBE4-BETA-CD, A SULFOBUTYL ETHER BETA-CYCLODEXTRIN, ON THE STABILITY AND SOLUBILITY OF O-6-BENZYLGUANINE (NSC-637037) IN AQUEOUS-SOLUTIONS [J].
GORECKA, BA ;
SANZGIRI, YD ;
BINDRA, DS ;
STELLA, VJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (01) :55-61
[3]  
He T., 1991, HIGH PERFORMANCE BIO, P789
[4]  
HEIGER D, 1992, HIGH PERFORMANCE CAP
[5]   THE EFFECT OF A MODIFIED BETA-CYCLODEXTRIN, SBE4-BETA-CD, ON THE AQUEOUS STABILITY AND OCULAR ABSORPTION OF PILOCARPINE [J].
JARVINEN, K ;
JARVINEN, T ;
THOMPSON, DO ;
STELLA, VJ .
CURRENT EYE RESEARCH, 1994, 13 (12) :897-905
[6]   BETA-CYCLODEXTRIN DERIVATIVES, SBE4-BETA-CD AND HP-BETA-CD, INCREASE THE ORAL BIOAVAILABILITY OF CINNARIZINE IN BEAGLE DOGS [J].
JARVINEN, T ;
JARVINEN, K ;
SCHWARTING, N ;
STELLA, VJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (03) :295-299
[7]   SULFOBUTYL ETHER BETA-CYCLODEXTRIN (SBE-BETA-CD) IN EYEDROPS IMPROVES THE TOLERABILITY OF A TOPICALLY APPLIED PILOCARPINE PRODRUG IN RABBITS [J].
JARVINEN, T ;
JARVINEN, K ;
URTTI, A ;
THOMPSON, D ;
STELLA, VJ .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1995, 11 (02) :95-106
[8]   SOLUBILIZATION OF A TRIPEPTIDE HIV PROTEASE INHIBITOR USING A COMBINATION OF IONIZATION AND COMPLEXATION WITH CHEMICALLY-MODIFIED CYCLODEXTRINS [J].
JOHNSON, MD ;
HOESTEREY, BL ;
ANDERSON, BD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (08) :1142-1146
[9]  
Rajewski R. A., 1990, THESIS U KANSAS LAWR
[10]   PRELIMINARY SAFETY EVALUATION OF PARENTERALLY ADMINISTERED SULFOALKYL ETHER BETA-CYCLODEXTRIN DERIVATIVES [J].
RAJEWSKI, RA ;
TRAIGER, G ;
BRESNAHAN, J ;
JABERABOANSARI, P ;
STELLA, VJ ;
THOMPSON, DO .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (08) :927-932